Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Mas se tiver dvidas sobre qual o melhor para si, contacte a nossa equipa farmacutica para um aconselhamento personalizado
For example, in the SELECT trial (17,600 patients with cardiovascular disease and obesity but without T2D), weekly subcutaneous Semaglutide (2.4 mg) reduced the risk of major adverse cardiovascular events (MACE heart attack, stroke, or cardiovascular death) by 20% compared to placebo (HR 0.80
Despite this progress, only 14% of patients remain on Wegovy after three years (Figure 3)
Competitive pricing with quantity discounts for large scale research projects
US$ 19.99
US$ 20.14
US$ 22.55
US$ 25.70
US$ 25.08
US$ 24.79
US$ 20.34
